Philip Padou, David Schwartz, Ben Bulkley, John Radak, Bernd Brust, Kelli Richard | GenomeWeb
Bio-Rad reported last week that board member Philip Padou has died at the age of 72.
 
Padou joined Bio-Rad’s Board in 1980, and he was VP and CFO of Ozier Perry and Associates until his retirement in 1991.
 
David Schwartz, chairman of Bio-Rad’s board, said in a statement that Padou was “a dedicated and valuable member” of the board.
 
The company said it will begin seeking a replacement for Padou as soon as possible.
 

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.